Bionime Corp. | Balance Sheet

Fiscal year is January-December. All values TWD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
662
866
836
989
487
472
Total Accounts Receivable
337
325
339
435
626
871
Inventories
311
327
347
311
364
412
Other Current Assets
121
24
19
11
13
14
Total Current Assets
1,432
1,542
1,542
1,746
1,489
1,770
Net Property, Plant & Equipment
2,984
2,938
2,870
2,770
2,763
2,773
Total Investments and Advances
3
2
4
-
30
30
Intangible Assets
41
32
26
17
12
9
Other Assets
58
143
117
99
57
4
Total Assets
4,524
4,667
4,567
4,647
4,375
4,589
ST Debt & Current Portion LT Debt
1,041
1,174
368
769
1,122
Accounts Payable
74
170
129
189
145
Income Tax Payable
3
12
7
36
27
Other Current Liabilities
190
251
187
270
266
Total Current Liabilities
1,308
1,607
692
1,264
1,559
Long-Term Debt
2,173
1,739
1,330
795
738
Provision for Risks & Charges
-
1
1
1
-
Deferred Taxes
7
9
6
14
23
Other Liabilities
-
-
-
-
-
Total Liabilities
3,482
3,349
2,025
2,060
2,297
Common Equity (Total)
1,042
1,318
2,542
2,587
2,078
Total Shareholders' Equity
1,042
1,318
2,542
2,587
2,078
Total Equity
1,042
1,318
2,542
2,587
2,078
Liabilities & Shareholders' Equity
4,524
4,667
4,567
4,647
4,375

About Bionime

View Profile
Address
No. 100 Daqing Street Section 2
Taichung TX 40242
Taiwan
Employees -
Website http://www.bionime.com
Updated 07/08/2019
Bionime Corp. engages in the provision of biotechnology and medical testing. It specializes in self monitoring blood glucose system covers self-monitor, hospital and clinic use, and accessories such as test strips and lancing device. The company was founded on April 14, 2003 and is headquartered in Taichung, Taiwan.